Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Psychopharmacology > Chapter 1: Principles of Pharmacology > Flashcards

Chapter 1: Principles of Pharmacology Flashcards

1
Q

Movement of a drug from the site of administration to the circulatory system.

A

Absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rapid tolerance formed during a single administration of a drug, as is the case with alcohol.

A

Acute tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug interactions characterized by the collective sum of the two individual drug effects.

A

Additive effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Attraction between a molecule and a receptor.

A

Affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Area in the medulla of the brain stem that is not isolated from chemicals in the blood. It is responsible for inducing a vomiting response when a toxic substance is present in the blood.

A

Area Postrema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Star-shaped cells of the nerve tissue that have numerous extensions and that modulate the chemical environment around neurons, metabolically assist neurons, and provide phagocytosis for cellular debris.

A

Astrocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The reduced effectiveness of a drug administered chronically that involves learning: either instumental or classical conditioning.

A

Behavioral tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Concentration of drug present in the blood that is free to bind to specific target sites.

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Inactivation of a drug through a chemical change, usually by metabolic processes in the liver.

A

Biotransformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fluid that surrounds the brain and spinal cord, providing cushioning that protects against trauma.

A

Cerebrospinal fluid (CSF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Repeated pairing of a neutral stimulus with an unconditioned stimulus. Eventually the neutral stimulus becomes a conditioned stimulus and elicits a (conditioned) response that is similar to the original unconditioned response.

A

Classical conditioning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drug that binds to a receptor but has little or no efficacy. When it competes with an agonist for receptor sites, it reduces the effect of the agonist.

A

Competitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Difference in the amount or concentration of a substance on each side of a biological barrier, such as the cell membrane.

A

Concentration gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tolerance to a specific drug can reduce the effectiveness of a another drug in the same class.

A

Cross-tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class of liver enzymes, in the microsomal enzyme group, responsible for both phase 1 and phase 2 biotransformation of psychoactive drugs.

A

Cytochrome P450 (CYP450)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Type of drug interaction involving binding to an inactive site, such as to proteins in the plasma, to bone, or to fat.

A

Depot binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Graph used to display the amount of biological change in relation to a given drug dose.

A

Dose–response curve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Type of experiment in which neither the patient nor the observer knows the treatment received by the patient.

A

double-blind experiment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Decrease in the number of receptors, which may be a consequence of chronic agonist treatment.

A

Down-regulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Molecular changes associated with a drug binding to a particular target site or receptor.

A

Drug action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Interaction between two drugs that share a metabolic system and compete for the same metabolic enzymes. Bioavailability of one or both increases.

A

Drug competition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

INACTIVE sites where drugs accumulate. There is NO biological effect from drugs binding at these sites, nor can they be metabolized.
Includes plasma proteins (e.g., albumin), muscle, and fat.

A

Drug depots

bound drug has no drug effect; drug remains in system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Alterations in physiological or psychological functions associated with a specific drug.

A

Drug effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

The extent to which a ligand-receptor binding initiates a biological action (e.g., the ability of an agonist to activate its receptor).

A

Efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Drug administration by oral or rectal routes.

A

Enteral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Increase in liver drug-metabolizing enzymes associated with repeated drug use.

A

Enzyme induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Reduction in liver enzyme activity associated with a specific drug.

A

Enzyme inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Method that involves administration of a drug into the cerebrospinal fluid surrounding the spinal cord.

A

Epidural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Large pores in endothelial cells allowing rapid exchange between blood vessels and tissue.

A

Fenestrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Term used to describe exponential elimination of drugs from the bloodstream.

A

First-order kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Phenomenon in which the liver metabolizes some of a drug before it can circulate through the body, particularly when the drug has been taken orally.

A

First-pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Application of DNA that encodes a specific protein to increase or block expression of the gene product to correct a clinical condition.

A

Gene therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Genetic variations in a population resulting in multiple forms of a particular protein.

A

Genetic polymorphisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Time required to remove half of the drug from the blood. It is referred to as t1/2.

A

Half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Drug delivery via an implanted pump (e.g., subcutaneous) that delivers regular, constant doses to the body or into the cerebral ventricles.

A

Infusion pump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Method that involves administration of a drug through the lungs.

A

Inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Small gaps between adjacent cells.

A

Intercellular clefts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Method that involves administration of a drug into the cerebrospinal fluid of the ventricles.

A

Intracerebroventricular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Method that involves administration of a drug into the brain tissue.

A

Intracranial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Injection technique that is the most common route of administration for small laboratory animals. The drug is injected through the abdominal wall into the peritoneal cavity—the space that surrounds the abdominal organs.

A

Intraperitoneal (IP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Method that involves administration of a drug into a muscle.

A

Intramuscular (IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Topical administration of a drug to the nasal mucosa.

A

Intranasal administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Method that involves administration of a drug directly into the bloodstream by means of a vein.

A

Intravenous (IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Substance that activates a receptor but produces the opposite effect of a typical agonist at that receptor.

A

Inverse agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Process involving the dissociation of an electrically neutral molecule into charged particles (ions).

A

Ionization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Molecule that selectively binds to a receptor.

A

Ligand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Type of tolerance to a drug that is characterized by a reduced amount of drug available at the target tissue, often as a result of more-rapid drug metabolism. It is sometimes also called drug disposition tolerance.

A

Metabolic tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Area in the hypothalamus that is not isolated from chemicals in the blood and where hypothalamic-releasing hormones are secreted for transport to the anterior pituitary gland.

A

Median eminence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Physical or behavioral changes not associated with the chemical activity of the drug–receptor interaction but with certain unique characteristics of the individual such as present mood or expectations of drug effects.

A

Nonspecific drug effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Drug that reduces the effect of an agonist, but does not compete at the receptor site. The drug may bind to an inactive portion of the receptor, disturb the cell membrane around the receptor, or interrupt the intercellular processes initiated by the agonist–receptor association.

A

Noncompetitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Area of pharmacology focusing on chemical substances that interact with the nervous system to alter behavior, emotions, and cognition.

A

Neuropsychopharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Area of pharmacology specializing in drug-induced changes to the function of cells in the nervous system.

A

Neuropharmacology

53
Q

Enzymes in liver cells responsible for metabolizing exogenous substances such as drugs.

A

Microsomal enzymes

54
Q

Type of learning in which animals learn to repond to obtain rewards and avoid punishment.

A

Operant conditioning

55
Q

Method that involves administering a drug through the mouth.

A

Oral administration (PO)

56
Q

Methods of drug administration that do not use the gastrointestinal system, such as intravenous, inhalation, intramuscular, transdermal, etc.

A

Parenteral

57
Q

Drugs that bind to a receptor but have low efficacy, producing weaker biological effects than a full agonist. Hence they act as agonists at some receptors and antagonists at others, depending on the regional concentration of full agonist.

A

Partial agonists

58
Q

An experimentally-derived measure of a drug’s lipid solubility used to predict its relative rate of movement across cell membranes.

A

Partition coefficient

59
Q

Movement of lipid-soluble materials across a biological barrier without assistance based on its concentration gradient, from higher to lower concentration.

A

Passive diffusion

60
Q

Reflexive and unconscious response to a stimulus.

A

Pavlovian

61
Q

Type of tolerance formed by changes in nerve cell functions in response to the continued presence of a drug.

A

Pharmacodynamic tolerance

62
Q

Study of physiological and biochemical interactions of a drug with the target tissue responsible for the drug’s effects.

A

pharmacodynamics

63
Q

The study of the genetic basis for variability in drug response among individuals (sometimes called pharmacogenomics).

A

Pharmacogenetics

64
Q

Factors that contribute to bioavailability: the administration, absorption, distribution, binding, inactivation, and excretion of a drug.

A

Pharmacokinetic

65
Q

Study of the actions of drugs and their effects on living organisms.

A

Pharmacology

66
Q

Lipid molecules that are major constituents of the cell membrane. They are composed of a polar head and two lipid tails.

A

Phospholipids

67
Q

Drug interaction characterized by two drugs reducing each other’s effectiveness in the body.

A

Physiological antagonism

68
Q

Type of vesicles that envelop and transport large molecules across the capillary wall.

A

Pinocytotic vesicles

69
Q

Substance that is pharmacologically inert, yet in many instances produces both therapeutic and side effects.

A

Placebo

70
Q

Measure of the amount of drug necessary to produce a specific response.

A

Potency

71
Q

Drug interaction characterized by an increase in effectiveness greater than the collective sum of the individual drugs.

A

Potentiation

72
Q

Those drugs that have an effect on thinking, mood, or behavior.

A

Psychoactive drugs

73
Q

Area of pharmacology specializing in drug-induced changes in mood, thinking, and behavior.

A

Psychopharmacology

74
Q

A neurochemical or drug that can bind to a particular receptor protein and alter the shape of the receptor to initiate a cellular response.

A

Receptor agonist

75
Q

A molecule that interacts with a receptor protein and produces no cellular effect after binding, and also prevents an “active” ligand from binding.

A

Receptor antagonist

76
Q

Group of receptors that respond to the same neurotransmitter but that differ from each other to varying degrees with respect to their structure, signaling mechanisms, and pharmacology.

A

Receptor subtypes

77
Q

Proteins located on the surface of or within cells that bind to specific ligands to initiate biological changes within the cell.

A

Receptors

78
Q

Drug delivery method, such as a suppository, used to deliver drugs via the lower intestine.

A

Rectal administration

79
Q

Enhanced response to a particular drug after repeated drug exposure.
(Reverse tolerance)

A

Sensitization

80
Q

Undesired physical or behavioral change associated with a particular drug.

A

Side effect

81
Q

Physical or behavioral changes associated with biochemical interactions of a drug with the target site.

A

Specific drug effects

82
Q

Condition characterized by better performance of a particular task that was learned in a drugged state in the same drugged state, rather than in a nondrugged state. Tasks learned in a nondrugged state are likewise performed better in a nondrugged state.

A

State-dependent learning

83
Q

The desired blood concentration of drug achieved when the absorption/distribution phase is equal to the metabolism/excretion phase.

A

Steady state plasma level

84
Q

Method that involves injection of a drug just below the skin.

A

Subcutaneous (SC)

85
Q

Any agent including a virus, drug, or radiation that induces abnormal fetal development, causing birth defects.

A

Teratogen

86
Q

Taking multiple blood samples to directly measure plasma levels of a drug after administration, to identify the optimum dosage for maximum therapeutic potential and minimal side effects.

A

Therapeutic drug monitoring

87
Q

Desired physical or behavioral changes associated with a particular drug.

A

Therapeutic effects

88
Q

The relationship between the drug dose that results in a toxic response compared to the dose required for the desired biological response. It is represented by the equation TI = TD50/ED50 where TD50 is the dose that is toxic for 50% of the population and ED50 is the effective dose for 50%.

A

Therapeutic index

89
Q

Connection between cells characterized by a fusing of adjoining cell membranes.

A

Tight junctions

90
Q

Decreased response to a drug as a direct result of repeated drug exposure.

A

Tolerance

91
Q

Method that involves administration of a drug through a mucous membrane such as the oral cavity, nasal mucosa, or vagina.

A

Topical

92
Q

Method that involves administration of a drug through the skin (e.g., with a patch).

A

Transdermal

93
Q

Increase in the number of receptors, which may be a consequence of denervation or of chronic antagonist treatment.

A

Up-regulation

94
Q

Use of a virus as a delivery system (called a vector) to carry a gene into the nuclei of target cells to alter protein synthesis.

A

Viral vector

95
Q

Term used to describe a constant rate of drug removal from the body, regardless of drug concentration in the blood.

A

Zero-order kinetics

96
Q

5 Pharmacokinetic factors

A
  1. Routes of administration
  2. Absorption and distribution
  3. Binding
  4. Inactivation
  5. Excretion
97
Q

6 Routes of Administration

A
  1. Oral/Rectal
  2. Intravenous
  3. Intraperitoneal
  4. Subcutaneous
  5. Intramuscular
  6. Inhalation
98
Q 
Oral administration (PO) 
3 Benefits?

2 Considerations?

A

Safe, self-administered, economical.

Degradation by stomach acid and enzymes.
Many factors can influence plasma concentrations

99
Q

4 Factors that influence absorption

A
  1. food in stomach
  2. type of food
  3. physical activity
  4. metabolism
100
Q

With rectal administration…

A

The drug may avoid first-pass metabolism depending on placement.

101
Q

Intravenous (IV) injection pros

A

Most rapid and accurate method.

102
Q

Intravenous (IV) injection cons

A

Rapid onset offers little time to correct an overdose or allergic reaction
Drug cannot be removed from the body

103
Q

Inhalation absorption is _____ and the drug effect is _____.

A

Absorption is rapid

Psychoactive drug effect is rapid

104
Q

Intranasal administration local effects

A

Relieving nasal congestion

105
Q

Intranasal administration systemic effects

A

Allergy relief

106
Q

Intranasal administration - 3 facts

A

By-passes the blood–brain barrier
Produces high brain concentrations.
Full absorption can occur within 15min

107
Q

The most important factor in determining plasma drug levels:

A

The rate of passage through cell membranes.

108
Q

Passive diffusion

A

Mean by which lipid soluble drugs can pass through the cell membrane

Movement is in a direction of higher to lower concentration.

The larger the concentration gradient, the faster the diffusion.

109
Q

4 factors affecting absorption & distribution:

A
  1. Rate stomach empties.
  2. Size and sex of individual
    A larger person has more body fluid to dilute a drug.
    Females tend to have less body fluid than males.
  3. Frequency and history of prior drug use
  4. Nonspecific factors characteristic of individuals and
    their environment
110
Q

Highest concentration of a drug will be distributed to area where blood flow is _____

A

greatest

111
Q

Lipid-soluble drugs can _____ brain tissue

A

easily enter

112
Q

Blood–brain barrier _____ of ionized molecules.

A

limits movement

113
Q

Fills the subarachnoid space around the brain and spinal cord, ventricles, and canals.

A

Cerebrospinal fluid (CSF)

114
Q

Separation between brain capillaries and the brain/CSF

A

Blood–brain barrier

115
Q

Vomit center

Located in the medulla

A

Area postrema

116
Q

Depot binding prevents drug from reaching the _____ or _____

A

target site or liver

117
Q

Drugs are eliminated via _____ and metabolites are excreted.

A

biotransformation (metabolism)

118
Q

Longer half-life could lead to accumulation, which increases potential for _____ and _____

A

side effects and toxicity

119
Q

When does zero order kinetics occur?

A

When drug levels are high and routes of metabolism or elimination are saturated.

Example: alcohol

120
Q

Liver enzymes that metabolize drugs.

A

Microsomal enzymes

121
Q

Microsomal enzymes lack strict _____ and can metabolize a wide variety of foreign chemicals (xenobiotics).

A

specificity

122
Q

_____ enzyme family are responsible for oxidizing most psychoactive drugs.

A

Cytochrome P450 (CYP450)

123
Q

4 Factors that modify biotransformation capacity include

A
  1. Enzyme induction
  2. Enzyme inhibition
  3. Drug competition
  4. Individual differences in age, gender, and genetics.
124
Q

Most drugs do not pass into neurons, but act on _____

A

surface receptors

125
Q

Neuropharmacology identifies drugs that act at _____

A

neurotransmitter receptors

126
Q

Neuropharmacology enhances or reduces _____.

A

normal functioning of the cell

127
Q

The “anticipatory” (conditioned) response is compensatory, meaning…

A

The environment associated with administration of the drug elicits physiological responses opposite to the effect of the drug. Ex: shooting heroine in a green bathroom routinely - body learns to anticipate and prepares itself.

128
Q

Drug dosage could be adjusted if an individual’s _____ is known.

A

Genetic makeup

Psychopharmacology (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions